These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25659916)

  • 1. Angiotensin receptor-neprilysin inhibitors in heart failure: a shifting paradigm.
    Vardeny O
    Evid Based Med; 2015 Apr; 20(2):61. PubMed ID: 25659916
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure: another new PARADIGM in treatment for heart failure?
    Geach T
    Nat Rev Cardiol; 2015 Jan; 12(1):4. PubMed ID: 25445135
    [No Abstract]   [Full Text] [Related]  

  • 3. Neprilysin inhibition for heart failure.
    McMurray JJ; Packer M; Solomon SD
    N Engl J Med; 2014 Dec; 371(24):2336-7. PubMed ID: 25494275
    [No Abstract]   [Full Text] [Related]  

  • 4. Neprilysin inhibition for heart failure.
    Hough A; Rosenstein R
    N Engl J Med; 2014 Dec; 371(24):2335-6. PubMed ID: 25494277
    [No Abstract]   [Full Text] [Related]  

  • 5. Neprilysin inhibition for heart failure.
    Galli A; Lombardi F
    N Engl J Med; 2014 Dec; 371(24):2335. PubMed ID: 25494276
    [No Abstract]   [Full Text] [Related]  

  • 6. [The PARADIGM-HF study].
    Tavazzi L; Volpe M
    G Ital Cardiol (Rome); 2014 Dec; 15(12):651-5. PubMed ID: 25533113
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club: in HF, angiotensin-neprilysin inhibition reduced mortality and HF hospitalization compared with enalapril.
    Schmitt BP
    Ann Intern Med; 2015 Feb; 162(4):JC2. PubMed ID: 25686189
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart failure and LCZ696].
    Sabourin G
    Perspect Infirm; 2015; 12(1):61. PubMed ID: 25651686
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart failure: LCZ696--a PARADIGM shift in treatment for heart failure.
    Lim GB
    Nat Rev Cardiol; 2014 Nov; 11(11):618. PubMed ID: 25223453
    [No Abstract]   [Full Text] [Related]  

  • 10. PARADIGM-HF--the experts' discussion.
    Jessup M; Fox KA; Komajda M; McMurray JJ; Packer M
    N Engl J Med; 2014 Sep; 371(11):e15. PubMed ID: 25184757
    [No Abstract]   [Full Text] [Related]  

  • 11. Neprilysin inhibition for heart failure.
    Timmis A
    N Engl J Med; 2014 Dec; 371(24):2336. PubMed ID: 25494278
    [No Abstract]   [Full Text] [Related]  

  • 12. Neprilysin inhibition--a novel therapy for heart failure.
    Jessup M
    N Engl J Med; 2014 Sep; 371(11):1062-4. PubMed ID: 25176014
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of angiotensin-neprilysin inhibition versus enalapril in patient with heart failure with a reduced ejection fraction.
    Ferrari L; Sada S;
    Intern Emerg Med; 2015 Apr; 10(3):369-71. PubMed ID: 25537439
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective Comparison of ARNi with ACE-I to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF): paragon of a study or further investigation paramount?
    Krum H
    Circulation; 2015 Jan; 131(1):11-2. PubMed ID: 25411157
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin receptor neprilysin inhibitors in older patients with heart failure.
    Sharkey AT; Ghafar MZ; O'Keeffe ST; Mulkerrin EC
    BMJ Evid Based Med; 2019 Feb; 24(1):5-7. PubMed ID: 29991523
    [No Abstract]   [Full Text] [Related]  

  • 16. Neprilysin Inhibition and the Treatment of Heart Failure: Recent Steps in the Right Direction.
    Bartell N; Frishman WH
    Cardiol Rev; 2017; 25(6):315-320. PubMed ID: 28984670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Hospital Initiation of Angiotensin Receptor-Neprilysin Inhibitors-The Time Is Now.
    Srivastava PK; Fonarow GC
    JAMA Cardiol; 2019 Mar; 4(3):195-196. PubMed ID: 30810709
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
    Ruggenenti P; Remuzzi G
    Eur J Heart Fail; 2015 May; 17(5):468-71. PubMed ID: 25914256
    [No Abstract]   [Full Text] [Related]  

  • 19. The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure.
    Lainscak M; Coats AJ
    Int J Cardiol; 2016 Jun; 212():187-9. PubMed ID: 27038730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic developments in the therapy of heart failure: lessons to be learned.
    Parker JD
    Eur Heart J; 2015 Aug; 36(30):1952-4. PubMed ID: 26088390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.